4//SEC Filing
Stephens Kristin 4
Accession 0001209191-22-022508
CIK 0001556263other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 5:04 PM ET
Size
4.8 KB
Accession
0001209191-22-022508
Insider Transaction Report
Form 4
Stephens Kristin
Chief Development Officer
Transactions
- Tax Payment
Common Stock
2022-04-01$1.12/sh−14,115$15,809→ 30,885 total
Footnotes (1)
- [F1]Represents shares used to cover tax withholding on a Restricted Stock Unit release.
Documents
Issuer
Syros Pharmaceuticals, Inc.
CIK 0001556263
Entity typeother
Related Parties
1- filerCIK 0001865490
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 5:04 PM ET
- Size
- 4.8 KB